CVSI OTC
CV Sciences, Inc.
1W: -6.6%
1M: -33.9%
3M: -37.6%
YTD: -80.0%
1Y: -74.5%
3Y: -73.3%
5Y: -95.2%
$0.01
-0.00 (-5.41%)
Weekly Expected Move ±21.7%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$14M
-12.2% ▼
5Y CAGR: -10.8%
Gross Profit
$7M
-5.8% ▼
5Y CAGR: -9.3%
Operating Income
-$992K
+54.7% ▲
Net Income
-$958K
+60.0% ▲
EPS (Diluted)
$-0.01
+61.8% ▲
EBITDA
-$562K
+69.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $20M | $16M | $16M | $16M | $14M |
| YoY Growth | -17.9% | -19.2% | -1.2% | -1.9% | -12.2% |
| Cost of Revenue | $11M | $11M | $9M | $9M | $7M |
| Gross Profit | $9M | $6M | $7M | $7M | $7M |
| Gross Margin | 43.0% | 34.2% | 44.3% | 45.6% | 49.0% |
| R&D Expenses | $1M | $307K | $151K | $118K | $122K |
| SG&A Expenses | $26M | $12M | $9M | $9M | $8M |
| Operating Expenses | $27M | $12M | $4M | $9M | $8M |
| Operating Income | -$18M | -$7M | $3M | -$2M | -$992K |
| Operating Margin | -92.0% | -42.3% | 21.0% | -13.9% | -7.2% |
| Interest Expense | $140K | $2M | $0 | $212K | $517K |
| Income Before Tax | -$16M | -$8M | $3M | -$2M | -$949K |
| Tax Expense | -$87K | -$47K | -$6K | -$8K | $9K |
| Net Income | -$16M | -$8M | $3M | -$2M | -$958K |
| Net Margin | -77.6% | -50.7% | 19.4% | -15.2% | -6.9% |
| EPS (Diluted) | $-0.14 | $-0.06 | $0.02 | $-0.01 | $-0.01 |
| EBITDA | -$14M | -$6M | $4M | -$2M | -$562K |
| Shares Outstanding | 108M | 138M | 154M | 176M | 184M |